TNFSF10 and neoplasm: Since necroptotic cell death promotes inflammation and immune activation it would be appealing to further test how TRAIL-induced necroptosis will affect tumor immunogenicity and treatment outcome especially in the context of cotreatment with immune checkpoint inhibitors.